ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,949.79
1.41%
Dow Jones
42,965.94
1.47%
US Dollar vs MXN
20.0869
-1.29%
Brent Oil
72.775
0.54%
Bitcoin
97,313.99
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) Noticias

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLSD
FechaHoraFuenteTítuloSímboloCompañía
19/12/202406:05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, EyeNASDAQ:CLSDClearside Biomedical Inc
25/11/202406:05GlobeNewswire Inc.Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United StatesNASDAQ:CLSDClearside Biomedical Inc
12/11/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
12/11/202415:05GlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
07/11/202408:05GlobeNewswire Inc.Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular EdemaNASDAQ:CLSDClearside Biomedical Inc
06/11/202406:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
04/11/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
04/11/202406:05GlobeNewswire Inc.Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
31/10/202406:05GlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024NASDAQ:CLSDClearside Biomedical Inc
22/10/202406:05GlobeNewswire Inc.Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
09/10/202405:30GlobeNewswire Inc.Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary OutcomesNASDAQ:CLSDClearside Biomedical Inc
27/08/202406:05GlobeNewswire Inc.Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
12/08/202415:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
12/08/202415:05GlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/08/202406:05GlobeNewswire Inc.Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:CLSDClearside Biomedical Inc
01/08/202406:05GlobeNewswire Inc.Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024NASDAQ:CLSDClearside Biomedical Inc
29/07/202415:05GlobeNewswire Inc.Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in ChinaNASDAQ:CLSDClearside Biomedical Inc
22/07/202411:00GlobeNewswire Inc.Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ETNASDAQ:CLSDClearside Biomedical Inc
11/07/202406:05GlobeNewswire Inc.Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory BoardNASDAQ:CLSDClearside Biomedical Inc
27/06/202406:05GlobeNewswire Inc.Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug DeliveryNASDAQ:CLSDClearside Biomedical Inc
12/06/202406:05GlobeNewswire Inc.Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit MeetingNASDAQ:CLSDClearside Biomedical Inc
21/05/202406:05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
10/05/202415:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
09/05/202415:05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/05/202415:15GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
30/04/202406:05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
16/04/202406:05GlobeNewswire Inc.Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
02/04/202406:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
18/03/202406:05GlobeNewswire Inc.Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical OfficerNASDAQ:CLSDClearside Biomedical Inc
12/03/202415:05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Su Consulta Reciente

NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
CCOM
OILBRENT
Brent Oil
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
NYSE
XOM
Exxon Mobil
NASDAQ
NVDA
NVIDIA
NYSE
VZ
Verizon Communications
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
BTCUSD
Bitcoin
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados